Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study

Low-dose prednisolone in early RA counteracts the negative impact of rheumatoid inflammation on bone tissue in the hip, a juxta-articular localisation. Thus bone mineral density was preserved in the femur in the P-group and 1CTP decreased rapidly. However, the systemic inflammatory consequences on bone could not be prevented in the lumbar spine, especially not in postmenopausal women, probably because of the combined effect of suppression of bone synthesis by prednisolone and the postmenopausal status.

 

 

Authors: Engvall, I. L.; Svensson, B.; Tengstrand, B.; Brismar, K.; Hafstrom, I. 

Title: Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study

Year: 2008

Journal: Arthritis Res Ther

Volume: 10

Issue: 6

Pages: R128

Pubmed Link: Click here.

Previous Article

EULAR evidence-based and consensus-based recommendations on the management of medium...

Next Article

Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib:...